海鸥药房最新医药资讯列表第3页-海鸥药房网

Current Location：Home>Medical Information

Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its merits
2022-03-04 16:03:35
While England’s drug-price watchdog continues to assess the value of Amgen’s lung cancer drug Lumykras, the company and the National Health Servi...
FDA clears Gleamer's X-ray AI for spotting broken bones
2022-03-04 16:03:26
A developer of artificial intelligence programs for scanning X-rays has received FDA clearance for a system that automatically highlights bone fr...
NCCN Recommends Ropeginterferon Alfa-2b in Clinical Practice Guidelines Update
2022-03-04 16:03:14
The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology has been revised to include ropeginterferon alfa-2b as a recom...
Frontline HMA Plus Venetoclax May Improve Outcomes in Secondary AML
2022-03-04 16:03:03
Treatment with a hypomethylating agent plus venetoclax followed by hematopoietic stem cell transplant could improve outcomes in patients with tre...
Nirsevimab significantly protected infants against RSV disease in Phase 3 trial
2022-03-04 16:02:06
Paris, March 3, 2022. The New England Journal of Medicine (NEJM) today published detailed results from a Phase 3 trial evaluating nirsevimab,...
FDA Approves Naloxone Auto-Injector as Countermeasure to High Potency Opioids
2022-03-04 15:57:36
The Food and Drug Administration (FDA) has approved Naloxone Auto-Injector 10mg (naloxone hydrochloride injection) for use by military person...
February 2022: 5 Notable Drug Approvals
2022-03-03 16:52:24
Carvykti (ciltacabtagene autoleucel) for Relapsed/Refractory Multiple Myeloma Carvykti is a B-cell maturation antigen (BCMA)-directed genetica...
Next-Generation Antibody-Drug Conjugates Make Their Mark in Breast Cancer
2022-03-03 16:44:56
In 2013, ado-trastuzumab emtansine (T-DM1; Kadcyla ) gained FDA approval for the treatment of patients with HER2-positive metastatic breas...
Analysis Uncovers Mechanisms of Resistance to BTK Inhibitors in R/R CLL
2022-03-03 16:41:12
On-target Bruton tyrosine kinase (BTK) mutations and downstream PLCγ2 mutations leading to escape of BTK inhibition may result in noncovalent...
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus (RSV) Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women
2022-03-03 15:57:28
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or R...

<<
<
2
3
4
>
>>
Jump to Page